Back to Treatments

Treatment

Zanubrutinib

1
Conditions
42
Trials
4,500
Participants
48%
Average Safety

Condition Evidence

Chronic lymphoid leukemia

42 trials · 4,500 participants

90% effectiveness · 48% safety
Zanubrutinib | DFDA